Omicron News and Research

RSS

An estimation of all-cause excess mortality for the United States between March 2020 and February 2022

Researchers estimated all-cause excess mortality for the US between March 2020 and February 2022.

27 Jun 2023

New study offers clues on how to future-proof covid-19 vaccines

New research examining how frequently our bodies produce broadly neutralizing antibodies (bnAbs) capable of thwarting a range of SARS-CoV-2 variants offers clues on the strategy tweaks that could potentially future-proof COVID-19 vaccines.

26 Jun 2023

Study reveals impact of age and variants on SARS-CoV-2 transmission: Insights from Toyama, Japan

Global spread of SARS-CoV-2 and its variants caused multiple epidemic waves. This study analyzes the effects of age and VOCs on transmission using contact tracing data in Toyama, Japan.

26 Jun 2023

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Researchers evaluated the impact of SARS-CoV-2 Wuhan-Hu-1 strain (WH1) immune imprinting on antibody-based immunological responses.

26 Jun 2023

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted population.

25 Jun 2023

New model could help speed up vaccine distribution during pandemics

A model for optimizing the dispensing of vaccines during pandemics that uses a new measure of success for such efforts has been developed by researchers at Weill Cornell Medicine, the Ithaca campus of Cornell University, Singapore University of Technology and Design and San Jose State University in California.

23 Jun 2023

Study yields important findings about COVID-19 vaccination and previous SARS-CoV-2 infection in children younger than 12 years

A recent study examined the effects of prior COVID-19 infection and vaccination on subsequent infection with the SARS-CoV-2 Omicron variant in children.

22 Jun 2023

CDC reports on vaccine effectiveness of bivalent COVID-19 vaccine among vaccinated vs. unvaccinated adults aged ≥65 years in 2022-23

CDC reported how coronavirus disease 2019 (COVID-19) mortality rates varied among unvaccinated and vaccinated adults aged ≥65 years.

19 Jun 2023

Researchers review the principles of universal vaccine development for key pandemic potential viruses

A recent review addressed the efforts to develop universal vaccines for viruses at family and genus levels.

16 Jun 2023

Study concludes a single intramuscular injection of adintrevimab provides prophylactic efficacy against COVID-19 without safety concerns

Researchers evaluated the prophylactic immune protection conferred by a single intramuscular injection of adintrevimab (ADG20) against symptomatic COVID-19.

16 Jun 2023

A new weapon against COVID: RBD-62 protein shows promising results in preventing severe disease

Researchers used aerosolized receptor binding domain (RBD)-62 with 1,000-fold enhanced binding affinity.

15 Jun 2023

Being "not up-to-date" on COVID-19 vaccination linked to lower risk of infection, study suggests

Researchers investigate whether not “up-to-date” individuals had a higher risk of COVID-19 than “up-to-date” individuals.

14 Jun 2023

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

CDC reports an outbreak involving Candida auris (C. auris) in Israel.

13 Jun 2023

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

A new study examines hospitalization and mortality rates from COVID-19 before and after the rollout of the vaccine in England.

11 Jun 2023

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

9 Jun 2023

Scientists unlock virus-fighting power with synthetic nanobody platform

Discovery and validation of nanobodies, a promising class of biologics, for viral infection prevention and treatment, including anti-SARS-CoV-2 nanobodies with enhanced neutralization properties through synergistic pairing. The study demonstrates the potential of nanobodies in developing effective therapies against viral infections.

8 Jun 2023

Study compares long-term consequences of COVID-19 between patients with rheumatic inflammatory diseases and healthy controls

Researchers used data from a long-term ongoing prospective cohort study in the Netherlands to compare the characteristics of long-COVID in inflammatory rheumatic diseases patients and healthy controls during the period when the SARS-CoV-2 Omicron subvariants, BA.1/BA.2 were dominant.

8 Jun 2023

Is discontinuing universal SARS-CoV-2 testing at hospital admission in England and Scotland associated with increased hospital-onset infections?

Researchers performed a time series analysis using public data sets from both nations to examine whether this discontinuation resulted in a surge in hospital-onset COVID-19 cases.

7 Jun 2023

What role did children play in household viral transmission during the COVID-19 pandemic, when enveloped virus rates were low, and relative proportions of COVID-19 were high?

Researchers performed a cohort study on a voluntary group in the United States.

6 Jun 2023

COVID-19 variants and severity influence heart issues associated with long COVID

Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID, according to a recent Houston Methodist study published in the European Heart Journal – Cardiovascular Imaging.

5 Jun 2023

Omicron News and Research

An estimation of all-cause excess mortality for the United States between March 2020 and February 2022

New study offers clues on how to future-proof covid-19 vaccines

Study reveals impact of age and variants on SARS-CoV-2 transmission: Insights from Toyama, Japan

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

New model could help speed up vaccine distribution during pandemics

Study yields important findings about COVID-19 vaccination and previous SARS-CoV-2 infection in children younger than 12 years

CDC reports on vaccine effectiveness of bivalent COVID-19 vaccine among vaccinated vs. unvaccinated adults aged ≥65 years in 2022-23

Researchers review the principles of universal vaccine development for key pandemic potential viruses

Study concludes a single intramuscular injection of adintrevimab provides prophylactic efficacy against COVID-19 without safety concerns

A new weapon against COVID: RBD-62 protein shows promising results in preventing severe disease

Being "not up-to-date" on COVID-19 vaccination linked to lower risk of infection, study suggests

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

Study validates vaccine effectiveness: COVID-19 shots cut hospitalization and mortality rates in England

Common diabetes drug prevents the development of long COVID, study finds

Scientists unlock virus-fighting power with synthetic nanobody platform

Study compares long-term consequences of COVID-19 between patients with rheumatic inflammatory diseases and healthy controls

Is discontinuing universal SARS-CoV-2 testing at hospital admission in England and Scotland associated with increased hospital-onset infections?

What role did children play in household viral transmission during the COVID-19 pandemic, when enveloped virus rates were low, and relative proportions of COVID-19 were high?

COVID-19 variants and severity influence heart issues associated with long COVID

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News